Altered DSCAM expression levels have been associated with several brain disorders, including DS, ASD, intractable epilepsy and bipolar disorder [6–11], and, possibly, Fragile X syndrome [3,4,12,13]. This evidence concerns the gene DSCAM and fragile X syndrome.